The impact of virtual admission on self-efficacy in patients with chronic obstructive pulmonary disease – a randomised clinical trial.

Source: Emme et al. 2013 - Pubmed ID: 24476457

Setting: Denmark, Hospital

Study design:

RCT-pro

 

Follow up: 3 months after discharge from hospital or virtual admission

Patient group:

Sample size:

Total: 52 (50)

IG: 25 (25)

CG: 27(25)

 

Inclusion criteria:

  • COPD
  • GOLD stage III-IV
  • Estimated duration of admission >two days
Type of technology:

Home monitoring

  • Touch screen with an embedded video-conference system
  • Spirometer
  • Pulse oximeter
  • Thermometer
Intervention:

Intervention: Patients are hospitalized in the Virtual Hospital and have 1-4 contacts/day, mean duration 19 min). Virtual ward rounds included medical treatment and implied measurements of vital signs, evaluation of medication plan and symptom management.

 

Duration: NA
Add on: NA

 

Control group: Received conventional hospital treatment and were discharged on the same criteria as the intervention group.

Clinical effect/ Patient safety:

Clinical effect:

  • Self-efficacy 3 days after discharge (The COPD self-efficacy scale’ (CSES)): →
  • Self-efficacy six weeks and three months after discharge:→

 

Patient safety: NA

Patient experiences/ Staff experiences:

Patient experiences: NA

 

Staff experiences: NA

Costs and organization:

Investment:
Equipment

  • Touch screen with an embedded video-conference system
  • Spirometer
  • Pulse oximeter
  • Thermometer

Running:

  • Training patients in using the telemedical and medical equipment
  • Installing equipment in the homes
  • Standard medication used for exacerbations in the homes
  • Call centre, organised by the hospital and manned by experienced nurses and doctors


Organization:
NA


Health care utilization:
NA

Scroll to Top

Information

“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)